Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2010 June;58(3) > Minerva Cardioangiologica 2010 June;58(3):343-55

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

REVIEWS  ECHOCARDIOGRAPHY UPDATE


Minerva Cardioangiologica 2010 June;58(3):343-55

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: English

Contrast echocardiography: mechanism of action, safety and clinical applications

Soliman O. I. I., De Jong N., Van Der Zwaan H. B., Galema T. W., Vletter W. B., Van Dalen B. M., Schinkel A. F. L., Ten Cate F. J., Geleijnse M. L.

Department of Cardiology, The Thoraxcenter, Biomedical Engineering, Erasmus MC, Rotterdam, The Netherlands


PDF  


Since its initial description by Gramiak and Shah in 1968, contrast echocardiography has become an established practice world-wide. Microbubbles have the unique property of being pure intravascular tracers. The basic rationale behind bubble imaging is the characteristic responses to ultrasound power that results in enhanced ultrasound images from the blood pool. Therefore, whenever there is blood pool there is a potential application for contrast ultrasound. Clinical applications of contrast echocardiography have been vastly grown from diagnostic applications such as detection of a persistent foramen ovale to drug delivery. This article reviews the mechanism of action, safety and clinical applications of contrast echocardiography.

top of page

Publication History

Cite this article as

Corresponding author e-mail

m.geleijnse@erasmusmc.nl